miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy

miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy

Immunotherapy is presently one of the most promising areas of investigation and development for the treatment of cancer. While immune checkpoint-blocking monoclonal antibodies and chimeric antigen receptor (CAR) T-cell-based therapy have recently provided in some cases valuable therapeutic options,...

Full description

Bibliographic Details
Main Authors: Maria Teresa Di Martino, Caterina Riillo, Francesca Scionti, Katia Grillone, Nicoletta Polerà, Daniele Caracciolo, Mariamena Arbitrio, Pierosandro Tagliaferri, Pierfrancesco Tassone
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
noncoding RNA
microRNA
miRNA
long noncoding RNA
lncRNA
RNA therapeutics
Online Access:https://www.mdpi.com/2072-6694/13/7/1587

Internet

https://www.mdpi.com/2072-6694/13/7/1587

Similar Items